PC
ADMA icon

PointState Capital’s ADMA Biologics ADMA Stock Holding History

PointState Capital’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-203,158
Closed -$1.64M – 91
2015
Q4 		$1.64M Hold
203,158
– – 0.04% 81
2015
Q3 		$1.7M Hold
203,158
– – 0.05% 78
2015
Q2 		$1.88M Hold
203,158
– – 0.02% 126
2015
Q1 		$1.99M Buy
+203,158
New +$2.05M 0.03% 109

Other funds holding ADMA

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $3.94B AUM 30.77% 1-Year Est. Return
JGC
J. Goldman & Co New York $2.16B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Telemetry Investments New York $42.8M AUM 0.06% 1-Year Est. Return